Abstract Tuberous sclerosis (TSC) is a heterogeneous trait. Since 1990, linkage studies have yielded putative TSC loci on chromosomes 9, 11, 12 and 16. Our current analysis, performed on 14 Dutch and British families, reveals only evidence for loci on chromosome 9q34 (TSC1) and chromosome 16p13 (TSC2). We have found no indication for a third locus for TSC, linked or unlinked to either of these chromosomal regions. The majority of our families shows linkage to chromosome 9. We have refined the candidate region for TSC1 to a region of approximately 5 cM between ABL and ABO.
Introduction
Tuberous sclerosis (TSC) is an autosomal dominant disorder, characterized by hamartomas that may affect numerous organ systems (for a review, see Gomez 1991) . Positional cloning has been hampered by locus heterogeneity. Linkage was initially reported to markers on chromosome 9q34 (Fryer et al. 1987) . However, these findings were subsequently disputed, until significance for locus heterogeneity was demonstrated and the existence of a chromosome-9-1inked locus (TSC!) was confirmed (Haines et al. 1991 a, b; Northrup et al. 1992) .
During the period 1990-1992, linkage studies in TSC were dominated by two main strategies: the development of more efficient methods for heterogeneity analysis and the search for other loci responsible for the disease. Sev-eral methods for linkage analysis under heterogeneity have been used. The HOMOG programs (Ott 1991) , implementing the admixture test (A-test), have been used successfully by several research groups (Haines et al. 1991 a, b; Northrup et al. 1992) . A more advanced application of the A-test, which we have designated the "imaginary chromosome approach" (ICA) (Janssen et al. 1990) , involves the synchronous analysis of multipoint linkage data from multiple candidate regions. The A-test based approaches are relatively powerful and provide an efficient tool for the assignment of the gene defect, in each family, to one of the various loci . Alternative transparent techniques that are not based on the A-test have supported the findings obtained with A-test based approaches .
Additional chromosomal locations for TSC have been sought since the demonstration of locus heterogeneity. A second locus was provisionally assigned to chromosome 11 (Smith et al. 1990 ) but subsequent heterogeneity analyses have failed to position a locus within the predicted region on 11q14-23 (Haines et al. 1991 a, b; or have attained marginal significance levels (Janssen et al. 1990) . A de novo translocation t(3;12) in a TSC patient led to the provisional assignment of a third locus to chromosome 12, through linkage analysis in 15 German families . However, a large collaborative heterogeneity analysis involving data from all three regions 9q34, 11q14-23 and 12q23.3 provided no evidence for either a locus on chromosome 11 or a locus on chromosome 12 . In 1992, Kandt et al. reported linkage to markers on the tip of chromosome 16p in five large non-chromosome-9-1inked TSC families. Apart from the incontrovertible evidence for a locus on 16pl3.3, the authors also showed a clear lack of evidence for loci on chromosome 11 or 12 in these families. However, since only non-chromosome-9-1inked families were studied, no comment on the importance, or even the existence, of a locus on 9q34 could be made. We planned a heterogeneity analysis, methodologically similar to previous studies ) and utilizing data from 9q34 and 16p13.3, with the aims of gaining a better insight into the TSC heterogeneity problem and of achieving more precise map positions for each locus.
Materials and methods
We selected 14 large families from a mixed group of 24 nuclear families and extended pedigrees from Cardiff and Rotterdam. Previously, simulation studies had been performed in order to determine the power of each family . Families that never showed two or more informative meioses were left out of the present analysis, because this type of family cannot contribute significantly, unless an extremely large number of families is available. Of the 14 selected families, 13 had previously been included in other analyses. The only changes with regard to family structure or affection status was the extension of family 1013 and the clarification of previously unknown statuses in this family. One new five-generation family (family 4210) has been added. We used the same genetic parameters {corresponding to a penetrance of 95% and a phenocopy rate of 2%) as in our previous study . We typed markers at ABL (dinucleotide repeat), D9S64 (dinucleotide repeat), ABO and D9S10 (MCTI36) on chromosome 9. Inter-marker distances (2, 3 and 2 cM, respectively) were taken from the report of the Second Chromosome 9 Workshop (Kwiatkowski et al. 1993) . At ABO, the serological typing was utilized, unless molecular typing of the O-allele had been performed. In family 1013, D9SI0 was uninformative and therefore replaced by the dinucleotide repeat D9S66, which maps on the same cosmid. We typed the markers D16S85 (3'HVR), D16S259 (pGGGI) and the dinucleotide repeats D16S291 (16AC2.5) and D16S283 (SM7) on chromosome 16. Inter-marker distances (6, 1 and 1 cM, respectively) were taken from Germino et al. (1992) or were inferred from physical distances. On both chromosomes, Iod scores were calculated at intervals of I cM. Outside the inter-marker regions, lod scores were calculated at several positions from 0%-50% recombination. Heterogeneity was studied using data from chromosomes 9 and 16 synchronously by ICA, allowing for two linked loci on the combined chromosomes, or three loci, one of which is unlinked. The data were analysed by the programs HOMOG2 and POINT4 from the HOMOG package (On 1991 ).
Results and discussion
Assuming homogeneity, we obtained a maximum cumulative Iod score Z~ = 1~ ...... of 4.14 at 10% recombination (O = 0.1) from ABL (Table l On chromosome 16 (under the assumption of homogeneity), we obtained a maximum lod score Z~,_ ~ ....... of 0.52. Under heterogeneity, the locus mapped at D16S291, with o~ = 0.35 and TSC1 placed at D9S64 (Fig. 2) (Z~.x~,x2 ~ ...... = 8.92 as discussed above). The unlinked position was associated with a Z(,,.x~.xe_-~,~,~ of 6.52 at ot = 0.43 and TSCI placed at D9S64. This results in an odds ratio of 2.5 9 102 : 1 (Z = 2.4) in favour of linkage of "TSC2" to chromosome 16. This result, although not independently significant according to the stringent guidelines that we have proposed elsewhere ) provides a clear confirmation of Kandt's finding (Kandt et al. 1992 ), since none of our families were in his Morgans study. Because of the limited amount of information in the chromosome-I6-1inked families, we could not define a narrow confidence interval for TSC2. The ratio of large and small families was about the same for both the TSC 1 and the TSC2 groups of families. In order to examine the possibility of a third traitcausing locus, we repeated the analysis. Instead of two c~-values, three were introduced, where cq and o~ 2 are as before and where cq denotes the proportion of families linked to neither region. A maximum lod score was obtained if or3 = 0%; thus, this data set yields no evidence for a third locus.
Our results demonstrate the usefulness of ICA. In order to avoid systematic bias, we have chosen to evaluate the lod scores under heterogeneity directly, rather than selecting families by their posterior probability of being linked to one of the regions, followed by an evaluation of their Z(a = j) values, as other authors have done (Haines et al. 1992a, b; Northrup et al. 1992 ). If we had used such a method, the (inflated) lod score in favour of linkage to 16pl 3.3 would have been 2,9 instead of 2.4.
During the course of this study, the TSC2 gene on chromosome 16 has been isolated (European Chromosome 16 TSC Consortium 1993). The gene maps less than 200 kb distal of D16S291. In one of the families (family 4079; posterior probability of being chromosome-16-kinked = 0.985), a reduced level of TSC2 transcript was demonstrated in all affected family members (European Chromosome 16 TSC Consortium 1993), thus confirming the involvement of TSC2 in this family. The excellent agreement between the statistical and the molecular localization of TSC2 is encouraging for a targeted search for TSC1 in the currently favoured area on chromosome 9. Molecular diagnosis should soon be feasible in large families.
